Skip to main content
1 May 2025
Last updated:
Tuesday 29 April 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
New opportunities for small molecules in cancer
Read more
Development timelines for new oncology drugs
Read more
Swiss companies weather the turmoil in 2022
Read more
Capturing the promise of p38 MAPK inhibition
Read more
Destiny Pharma advances strategy against bacteria
Read more
HIV vaccine remains elusive but antivirals deliver value
Read more
FDA guides on accelerated approvals in oncology
Read more
Stock values decline and companies restructure
Read more
Adrenomed prepares global study in septic shock
Read more
Oncology pipeline marked by multiple therapy types
Read more
Pagination
First page
« First
Previous page
‹‹
…
Page
6
Page
7
Page
8
Page
9
Current page
10
Page
11
Page
12
Page
13
Page
14
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
